This recording captures our PAG31 workshop, highlighting the transformative impact of DNBSEQ™ technology on Agrigenomics, improving sequencing accuracy and cost-effectiveness. The technology eliminates index hopping and clonal errors, enhancing accuracy, flexibility, and accessibility.
PCR-free whole genome sequencing with DNBSEQ™ technology offers a direct, accurate way to analyze genomes by eliminating PCR amplification biases. This advancement enhances sequencing reliability for genetics research and clinical diagnostics, facilitating deeper genetic insights and personalized medicine.
At the American Society for Human Genetics in Washington D.C., geneticists worldwide were briefed on Complete Genomics’ DNBSEQ™ revolutionizing full genome sequencing, the use of DNBSEQ-T7 in clinical labs for structural variant detection, and a University of Massachusetts researcher’s use of STOmics’s Stereo-Seq and DNBSEQ-T7 data.
The integration of Whole Genome Sequencing (WGS) for ultrasensitive detection and monitoring of Minimal Residual Disease (MRD) through DNA Nanoball Sequencing represents a significant advancement in cancer diagnostics.
Whether you have questions about our products, need assistance with genomic solutions, or just want to learn more about our technology, our team is ready to assist.